Cargando…
Microvesicles as a Biomarker for Tumor Progression versus Treatment Effect in Radiation/Temozolomide-Treated Glioblastoma Patients
The standard of care for glioblastoma (GB) is surgery followed by concurrent radiation therapy (RT) and temozolomide (TMZ) and then adjuvant TMZ. This regime is associated with increased survival but also increased occurrence of equivocal imaging findings, e.g., tumor progression (TP) versus treatme...
Autores principales: | Koch, Cameron J., Lustig, Robert A., Yang, Xiang-Yang, Jenkins, Walter T., Wolf, Ronald L., Martinez-Lage, Maria, Desai, Arati, Williams, Dewight, Evans, Sydney M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311040/ https://www.ncbi.nlm.nih.gov/pubmed/25500085 http://dx.doi.org/10.1016/j.tranon.2014.10.004 |
Ejemplares similares
-
2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma
por: Schwab, Robert D., et al.
Publicado: (2018) -
Improved Methods to Generate Spheroid Cultures from Tumor Cells, Tumor Cells & Fibroblasts or Tumor-Fragments: Microenvironment, Microvesicles and MiRNA
por: Lao, Zheng, et al.
Publicado: (2015) -
Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide
por: Tieu, Minh Thi, et al.
Publicado: (2015) -
Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma
por: Pandey, Arvind, et al.
Publicado: (2021) -
Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve
por: Koukourakis, Michael I, et al.
Publicado: (2016)